EGFR and lung adenocarcinoma: TP53 mutations have been associated with better engraftment of EGFR-mutant lung adenocarcinomas in PDX models previously50 and we speculate that, in LUAD tumors, higher chromosomal instability might represent an advantage in adapting to novel environments.